Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 3 Issue: 6, December

Hypoxia Inducible Factor as a Cancer Drug Target

Volume:3   Issue: 6
Pp: 391-405
Sarah J. Welsh and Garth Powis
DOI: 10.2174/1568009033481732
Published on: 01 March, 2012

Nitric Oxide-Releasing Non Steroidal Anti-Inflammatory Drugs: A New Generation of Anti-Tumoral Molecules

Volume:3   Issue: 6
Pp: 407-426
Christian Lavagna, Piero Del Soldato, Jean-Luc Burgaud and Patrick Rampal
DOI: 10.2174/1568009033481750
Published on: 01 March, 2012

Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies

Volume:3   Issue: 6
Pp: 427-432
E. Fonsatti, L. Sigalotti, P. Arslan, M. Altomonte and M. Maio
DOI: 10.2174/1568009033481741
Published on: 01 March, 2012

Thomsen-Friedenreich Disaccharide Immunogenicity

Volume:3   Issue: 6
Pp: 433-443
Fernando J. Irazoqui and Gustavo A. Nores
DOI: 10.2174/1568009033481714
Published on: 01 March, 2012

Metabolic Biomarker and Kinase Drug Target Discovery in Cancer Using Stable Isotope-Based Dynamic Metabolic Profiling (SIDMAP)

Volume:3   Issue: 6
Pp: 445-453
Laszlo G. Boros, Daniel J. Brackett and George G. Harrigan
DOI: 10.2174/1568009033481769
Published on: 01 March, 2012

Cyclooxygenase Inhibition and Mechanisms of Colorectal Cancer Prevention

Volume:3   Issue: 6
Pp: 455-463
Timothy A. Chan
DOI: 10.2174/1568009033481723
Published on: 01 March, 2012